Ipca Laboratories, a pharma company, is a potential buy as it has recorded a breakout from a falling trendline resistance and a Cup & Handle formation. Short-term traders can buy the stock, which has risen over 2% in a week and more than 7% in a month, with a possible target towards Rs 900 level in the next few weeks. Experts suggest placing a stop-loss below Rs 800 on a closing basis. The stock is trading above short-term moving averages on the daily chart and has a Relative Strength Index of 65.8.
Subscribe To Our Free Newsletter |